Posted by Michael Wonder on 12 Nov 2025
PHARMAC to fund five medicines for multiple sclerosis, breast cancer, eye conditions, and lung cancer
12 November 2025 - New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer will benefit from five medicines that PHARMAC will fund from 1 December 2025.
The funding decision includes new treatments and faster to administer versions of existing medicines, secured through a multi-product agreement with Roche. Around 1,700 people are expected to benefit in the first year, increasing to 4,000 people after five years.
